TherapeuticsMD (TXMD) Stock Statistics & Valuation Metrics

TherapeuticsMD has a market cap or net worth of $12.50M. The enterprise value is $13.96M.

TherapeuticsMD has 11,574,362 shares outstanding. The number of shares has decreased by -2.65% in one year.

TherapeuticsMD’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -12.72%.

The current PE Ratio of TherapeuticsMD is ―. TherapeuticsMD’s PEG ratio is ―.

In the last 12 months, TherapeuticsMD had revenue of 1.76M and earned -2.18M in profits. Earnings per share was -0.19.

In the last 12 months, operating cash flow was 1.34M and capital expenditures 0.00, giving a free cash flow of 1.03M billion.

TherapeuticsMD pays an annual dividend of ―, resulting in a dividend yield of ―

TherapeuticsMD upcoming earnings date is Nov 17, 2025, Before Open (Confirmed).

TherapeuticsMD as a current ratio of 2.37, with Debt / Equity ratio of 20.95%

In the past 12 months, TherapeuticsMD has paid -31.00K in taxes.

TherapeuticsMD EV to EBITDA ratio is -4.03, with an EV/FCF ratio of 10.29.

TherapeuticsMD has $6.07M in cash and marketable securities with $5.72M in debt, giving a net cash position of -$351.00K billion.

Gross margin is 92.34%, with operating margin of -270.30%, and net profit margin of -123.85%.

The average price target for TherapeuticsMD is ―, which is 11.43% higher than the current price. The consensus rating is ―